What Has Been the Progress and Growth of the Ventral Hernia Treatment Market in Recent Years?
The ventral hernia treatment market has seen considerable growth due to a variety of factors.
• The market size for ventral hernia treatment has seen significant growth in the recent past. The market, which is estimated to be worth $4.87 billion in 2024, is projected to increase to $5.23 billion in 2025, showcasing a compound annual growth rate (CAGR) of 7.5%.
This growth trajectory in the historic period can be credited to various factors such as the rise in obesity cases, heightened awareness about ventral hernias, an aging population, increase in disposable income, and growing demand for minimally invasive surgical procedures.
What Can Be Expected from the Ventral Hernia Treatment Market Size?
The ventral hernia treatment market is expected to maintain its strong growth trajectory in upcoming years.
• The market for ventral hernia treatment is anticipated to experience a significant rise in its market value in the approaching years, with projections suggesting it could reach $6.90 billion by 2029, thanks to a compound annual growth rate (CAGR) of 7.2%.
The predicted growth for this period can be traced back to factors such as increased requirements for outpatient procedures, a surge in healthcare expenditure, heightened governmental initiatives, growing demand for hernia rectification surgeries, and escalated investments in research and development. Key trends expected within this time frame encompass advancements in hernia rectification devices, development of bioabsorbable materials, strategic partnerships, the introduction of robotic-aided surgery tools, and remote monitoring systems.
What Are the Critical Driver Fuelling The Ventral Hernia Treatment Market's Growth?
The escalating number of obesity cases is anticipated to promote the development of the ventral hernia treatment market. Obesity, a medical issue manifested by an exaggerated level of body fat, significantly affects a person's health. Reasons for the rising prevalence of obesity include unhealthy diet, inactive lifestyle, genetic predisposition, insufficient exercise, environmental elements, and emotional pressure. Ventral hernia treatment aids obese individuals by dealing with complications ensuing from excessive weight. It provides relief to the strained abdominal wall, lessens the possibility of hernia recurrences, and bolsters overall abdominal strength, which is pivotal in facilitating movement and fostering healthier lifestyle decisions in individuals dealing with obesity. For example, in March 2024, the World Health Organization (WHO), an intergovernmental agency based in Switzerland, reported that about one in eight people globally were dealing with obesity. This comprised 2.5 billion adults (18 years and above) who were overweight, with 890 million grappling with obesity. Among adults, 43% were overweight, and 16% were identified as obese. Furthermore, the total count of overweight children below 5 years of age hit 37 million. Consequently, the rising prevalence of obesity stimulates the ventral hernia treatment market.
How Is The Ventral Hernia Treatment Market segmented?
The ventral hernia treatment market covered in this report is segmented –
1) By Type: Epigastric (Stomach Area) Hernia, Umbilical (Belly Button) Hernia, Incisional Hernia
2) By Diagnosis: Ultrasound, Computed Tomography (CT) Scan, Magnetic Resonance Imaging (MRI)
3) By Surgery: Open Hernia Surgery, Laparoscopic Surgery, Robotic Hernia Surgery
4) By End Users: Hospitals, Ambulatory Surgical Centres, Clinics
Subsegments:
1) By Epigastric (Stomach Area) Hernia: Small Epigastric Hernia, Large Epigastric Hernia
2) By Umbilical (Belly Button) Hernia: Congenital Umbilical Hernia, Acquired Umbilical Hernia
3) By Incisional Hernia: Primary Incisional Hernia, Recurrent Incisional Hernia
Pre-Book The Ventral Hernia Treatment Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Emerging Market Trends Are Altering The Ventral Hernia Treatment Industry?
Leading corporations in the ventral hernia treatment market are honing their focus on technological advancements, including laparoscopic and open hernia mesh fixation devices, with the goal of enhancing surgical outcomes, minimizing complications, and expediting patient recovery. These devices are essentially medical implements used to secure mesh during hernia repair procedures, employing either minimally invasive (laparoscopic) or conventional open surgical methods. In an example of this, TELA Bio Inc., a US-based medical tech firm, rolled out the LIQUIFIX FIX8 laparoscopic and LIQUIFIX precision open hernia mesh fixation devices on the US market in March 2024. LIQUIFIX FIX8 is utilized for minimally invasive reparations whereas LIQUIFIX precision is employed for open femoral and inguinal hernia reparations. These devices have received FDA approval and use liquid anchors to secure mesh without tissue penetration, thereby curbing trauma and complications. Considering the annual figure of over 1.2 million hernia procedures in the U.S., LIQUIFIX offers accuracy and safety in delicate areas and reduces the potential risks of vascular or nerve damage.
Who Are the Key Players In The Ventral Hernia Treatment Market?
Major companies operating in the ventral hernia treatment market are:
• Johnson And Johnson Services Inc.
• AbbVie
• Abbott Laboratories
• Medtronic Plc
• Becton
• Dickinson and Company (BD)
• Baxter International Inc.
• Braun Melsungen AG
• Zimmer Biomet
• Olympus Corporation
• W.L. Gore and Associates Inc
• STERIS Plc
• Cook Medical Inc.
• KARL STORZ
• Cooper University Health Care
• Mölnlycke Health Care
• Integra LifeSciences Holdings
• ConMed Corporation
• Aesculap Inc
• Richard Wolf GmbH
• Ethicon Inc
• Tela Bio
• Microline Surgical
• Hernia Mesh S.R.L.
• Insightra Medical Inc
• Advanced MedTech Solutions Pvt Ltd.
What Is The Most Dominant Region In The Ventral Hernia Treatment Market?
North America was the largest region in the ventral hernia treatment market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the ventral hernia treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
